Gilead Sciences (GILD) Falls: Stock Goes Down 7.3% - Tale of the Tape
April 11 2014 - 9:00AM
Zacks
Gilead Sciences Inc. (GILD) saw
a big move last session, as the company’s shares fell by over 7% on
the day. The move came on pretty good volume too with far more
shares changing hands than in a normal session. This continues the
recent downtrend for GILD, as the stock is now down almost 18% in
the past one-month time frame.
This biopharmaceutical company has seen a flat track record when it
comes to current year estimate revisions over the past few weeks,
and the consensus for earnings hasn’t been in a trend either. This
recent price action is discouraging, so make sure to keep a close
watch on this firm in the near future, and especially on earnings
estimates following the recent slump.
Gilead Sciences currently has a Zacks Rank #3 (Hold) while its
Earnings ESP is 0.0%.
Some better-ranked stocks in the same sector include
Alexion Pharmaceuticals, Inc. (ALXN),
Myriad Genetics Inc. (MYGN) and ANI
Pharmaceuticals, Inc. (ANIP). ANI pharma and Myriad
Genetics carry a Zacks Rank #1 (Strong Buy) while Alexion carries
Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research?
Today, you can download 7 Best Stocks for the Next 30
Days. Click to get this free report >>
ALKERMES INC (ALKS): Free Stock Analysis Report
ANI PHARMACEUT (ANIP): Free Stock Analysis Report
GILEAD SCIENCES (GILD): Free Stock Analysis Report
MYRIAD GENETICS (MYGN): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
ANI Pharmaceuticals (NASDAQ:ANIP)
Historical Stock Chart
From Apr 2024 to May 2024
ANI Pharmaceuticals (NASDAQ:ANIP)
Historical Stock Chart
From May 2023 to May 2024